期刊文献+

载紫杉醇脂质微泡联合超声破泡技术体外抑制多发性骨髓瘤细胞的研究 被引量:3

The inhibitory effect of paclitaxel-loaded lipid microbubbles combined with ultrasound on multiple myeloma cells in vitro
原文传递
导出
摘要 目的 观察载紫杉醇(PTX)的脂质微泡(MBs)联合超声(US)辐照体外作用于人多发性骨髓瘤U266细胞的效应.方法 采用机械振荡法制备PTX-MBs,镜下观察形态,检测其粒径、载药率、包封率和稳定性.检测单纯超声对细胞增殖和凋亡的影响.设Control组(Ⅰ)、PTX组(Ⅱ)、PTX+ US组(Ⅲ)、PTX-MBs组(Ⅳ)、PTX-MBs+ US组(Ⅴ),细胞计数试剂盒(CCK-8)法检测细胞的存活率,流式细胞术检测细胞的凋亡,软琼脂克隆实验检测细胞的克隆形成率.结果 PTX-MBs平均粒径为(353.9±25.7) nm,包封率为(86.25±7.31)%,载药率为(20.09±3.46)%.0.5 W/cm2的超声作用40 s对细胞增殖和凋亡无明显影响.各实验组中,Ⅴ组的细胞存活率[(32.89±5.59)%]较其他组[Ⅰ组:(98.42±1.47)%,Ⅱ组:(63.41±2.42)%,Ⅲ组:(58.79±4.16)%,Ⅳ组:(93.39±3.21)%]明显降低(P<0.05),Ⅴ组的细胞凋亡率[(28.48±3.89)%]较其他组[Ⅰ组:(3.03±1.09)%,Ⅱ组:(16.69±3.14)%,Ⅲ组:(16.84±1.11)%,Ⅳ组:(4.43±1.58)%]明显增强(P<0.05),Ⅴ组细胞的软琼脂克隆形成率[(6.00±1.00)%]较其他组[Ⅰ组:(35.00±5.00)%,Ⅱ组:(23.67±1.53)%,Ⅲ组:(20.00±2.65)%,Ⅳ组:(32.33±5.03)%]明显降低(P<0.05).结论 PTX-MBs是良好的药物传递载体,联合超声辐照体外作用于多发性骨髓瘤细胞可显著抑制细胞增殖、诱导细胞凋亡以及抑制细胞克隆形成. Objective To prepare paclitaxel-loaded lipid microbubbles (PTX-MBs) and investigate the effect of the MBs combined with ultrasound on multiple myeloma U266 cells in vitro.Methods PTX-MBs prepared by mechanic vibration method were observed under microscope.The size distribution, drug-loading efficiency and encapsulation efficiency were further detected.Ultrasound (US) was simply applied to multiple myeloma cells to observe the inhibitory effects.Cells were divided into Control group (Ⅰ), PTX group(Ⅱ), PTX + US group(Ⅲ), PTX-MBs group(Ⅳ), PTX-MBs + US group(Ⅴ).The inhibitory effect on cell proliferation was detected by cell counting kit-8 (CCK-8) method, the cell apoptosis was detected by flow cytometry (FCM), and the clone formation rate was detected by soft agar cloning method.Results PTX-MBs has good dispersion with the size [(353.9 ± 25.7) nm], encapsulation efficiency [(86.25 ± 7.31) %], and drug-loading efficiency [(20.09 ± 3.46) %].Ultrasound at 0.5 W/cm2 for40 s did no harm to cells.The survival rate was lower in PTX-MBs + US group[(32.89 ± 5.59) %] than in other groups [Group Ⅰ : (98.42 ± 1.47) %, Group Ⅱ : (63.41 ± 2.42) %, Group Ⅲ : (58.79 ±4.16)%, Group Ⅳ: (93.39 ±3.21)%, P〈0.05].The apoptosis rate was higher in PTX-MBs + US group [(28.48 ± 3.89) %] than in other groups [Group Ⅰ : (3.03 ± 1.09) %, Group Ⅱ : (16.69 ± 3.14) %, Group Ⅲ: (16.84 ± 1.11) %, Group Ⅳ : (4.43 ± 1.58) %, P 〈 0.05].The clone formation rate was higher in PTX-MBs + US group [(6.00 ± 1.00) %] than in other groups [Group Ⅰ : (35.00 ± 5.00) %, Group Ⅱ : (23.67 ± 1.53) %, Group Ⅲ : (20.00 ± 2.65) %, Group Ⅳ : (32.33 ± 5.03) %, P 〈 0.05].Conclusion As drug delivery system, PTX-MBs can inhibit the proliferation, induce the apoptosis and inhibit the clone formation of multiple myeloma cells when combined with ultrasound.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第11期2792-2795,共4页 Chinese Journal of Experimental Surgery
基金 中央高校基本科研业务费专项资金资助项目(242015k40016) 国家重大科学研究计划项目(2011CB933500).
关键词 多发性骨髓瘤 超声微泡 紫杉醇 Multiple myeloma Ultrasound microbubbles Paclitaxel
  • 相关文献

参考文献15

  • 1李勇华,侯健.多发性骨髓瘤的发病机制[J].中国全科医学,2007,10(18):1492-1495. 被引量:17
  • 2董作仁,姚丽.多发性骨髓瘤的临床表现与诊断思维提示[J].中国全科医学,2007,10(18):1497-1498. 被引量:15
  • 3Yang CP,Xiong F,Wang J,et al. Anti-ABCG2 monoclonal antibody in combination with paclitaxel nanoparticles against cancer stem-like cell activity in multiple myeloma[ J]. Nanomedicine,2014,9( 1 ) :45-60.
  • 4Cochran MC, Eisenbrey J, Ouma RO, et al. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery [ J ]. Int J Pharm,2011,414 (1-2) : 161-170.
  • 5Yan F, Li L, Deng Z, et al. Paclitaxel-liposome-microbubble comple- xes as ultrasound-triggered therapeutic drug delivery carriers [ J ]. J Control Release,2013,66 (3) :246-255.
  • 6Wang L,Li L, Guo Y,et al. Construction and in vitroin vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer [ J ]. Prostate,2013,73 ( 11 ) : 1147-1158.
  • 7朱梅,张萍,谭开彬,梁红敏,李睿,刘政.反相高效液相色谱法检测紫杉醇微泡的载药量及包封率[J].昆明医学院学报,2008,29(6):16-19. 被引量:2
  • 8Niu C, Wang Z, Lu G, et al. Doxombicin loaded superparamagnetic PLGA-iron oxide muhifunctional microhnbbles for dual-mode US/MR imaging and therapy of metastasis in lymph nodes [ J ]- Biomaterials, 2013 34(9) :2307-2317.
  • 9Liu H, Chang S, Sun J, et al. Ultrasound-mediated destruction of LHRHa-targetod and paclitaxel-looded lipid mierobubbles induces proliferation inhibition and apoptosis in ovarian cancer cells[ J]. Mol Pharm,2014,11 ( 1 ) :40-48.
  • 10Zhang Y, Hu H, Song L, et al. Epirubicin-mediated expression of miB-302b is involved in osteosarcoma apoptosis and cell cycle regula- tion[J]. Toxicol Lett,2013,222( 1 ) :1-9.

二级参考文献32

  • 1张天弼,廖建军.多发性骨髓瘤117例分析[J].中国基层医药,2006,13(6):1018-1019. 被引量:5
  • 2CROSASSO P, CERUTI M, BRUSA P, et al. Prepara tion, characterization and properties ofsterically stabilized paclitaxel containing liposome [J ]. J Controlled Release, 2000,63:19 - 30
  • 3高中.现代药物新剂型新技术[M].北京:人民军医出版社,2002.229-252.
  • 4Higgins MJ,Fonseca R.Genetics of multiple myeloma[J].Best Pract Res Clin Haematol,2005,18:525-536.
  • 5Hideshima T,Bergsagel PL,Kuehl WM,et al.Advances in biology of multiple myeloma:clinical applications[J].Blood,2004,104:607-18.
  • 6Fonseca R,Barlogie B,Bataille R,et al.Genetics and cytogenetics of multiple myeloma:a workshop report[J].Cancer Res,2004,64:1546-1558.
  • 7Bergsagel PL,Kuehl WM.Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma[J].Immunol Rev,2003,194:96-104.
  • 8Orlowski RZ.Initial therapy of multiple myeloma patients who are not candidates for stem cell transplantation[J].Hematology Am Soc Hematol Educ Program,2006:338-347.
  • 9Hideshima T,Podar K,Chauhan D,et al.Cytokines and signal transduction[J].Best Pract Res Clin Haematol,2005,18:509-524.
  • 10Podar K,Anderson KC.The pathophysiologic role of VEGF in hematologic malignancies:therapeutic implications[J].Blood,2005,105:1383-1395.

共引文献32

同被引文献26

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部